Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · September 18, 2023

Utility of the MAST Score in Predicting Major Adverse Liver Outcomes, Hepatocellular Carcinoma, Liver Transplantation, and Liver-Related Death

Clinical Gastroenterology and Hepatology


Additional Info

Clinical Gastroenterology and Hepatology
MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death
Clin. Gastroenterol. Hepatol. 2023 Sep 01;21(10)2570-2577.e1, E Truong, JA Gornbein, JD Yang, N Noureddin, SA Harrison, N Alkhouri, M Noureddin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading